General Catalyst is a venture capital firm that funds early-stage and growth companies across sectors including consumer, enterprise software, fintech, crypto, and healthcare. Based in San Francisco with offices in Cambridge, Massachusetts and other locations, it provides capital and strategic guidance to help entrepreneurs build scalable, durable businesses. The firm emphasizes the use of technology, including artificial intelligence, to accelerate growth and drive meaningful impact. General Catalyst partners with management teams to support product development, go-to-market strategies, and organizational growth, aiming to back companies with potential for wide adoption and long-term value creation, rather than focusing solely on near-term exits.

OrbiMed is a global healthcare-focused investment firm founded in 1989 and headquartered in New York. It manages assets across public and private markets and pursues opportunities across the healthcare spectrum, including biopharmaceuticals, medical devices, diagnostics, digital health, and health services. The firm invests in startups, growth-stage companies, and established entities, leveraging scientific and medical expertise to support development and commercialization. It also offers financing solutions such as structured debt and royalty monetization for intellectual property and medical diagnostics.

SOSV is a global venture capital firm that provides early-stage and seed investments alongside structured accelerator programs and deeply resourced facilities to accelerate product development. Focused on deep tech, human and planetary health, and cross-border software, SOSV backs startups from pre-seed onward and runs programs that accelerate technical development, regulatory strategy, and fundraising. The firm maintains labs and engineering spaces with specialist staff in multiple regions, including the United States and Asia, to support portfolio companies in biosafety, chemistry, mechatronics, analytics, and electrical engineering. Programs such as HAX and other live events offer founders access to prototyping, testing, and investor networks. Annually, SOSV makes around sixty pre-seed investments (up to roughly $550k each) and participates in numerous follow-on rounds, leveraging a global portfolio and extensive co-investor network to help deeply technical startups scale and reach markets.

Alumni Ventures is a venture capital firm based in Manchester, New Hampshire, with offices in New York, Boston, Menlo Park, Chicago, London, and Tokyo. It enables accredited investors, especially alumni networks, to access diversified venture opportunities by co-investing alongside leading venture capital firms. Through funds, syndicates, and investing clubs, it sources opportunities across stages and geographies, conducts rigorous due diligence, and aims for transparent, founder-friendly support. The firm backs a diversified portfolio of startups, including more than 1,600 companies, and has attracted substantial committed capital and a large community of individual investors, underscoring its mission to democratize access to venture capital while partnering with established VC firms.

RA Capital Management is a Boston-based investment firm focused on healthcare, life sciences, and planetary health, investing in public and private companies across stages from seed to late-stage financings. The firm emphasizes evidence-based, science-led investing guided by internal research capabilities, including TechAtlas. It operates Raven, a biomedical innovation incubator that supports entrepreneurs and developers, and pursues value creation through collaborative partnerships, often co-investing and taking board positions. With a multidisciplinary, data-driven approach, RA Capital seeks to back management teams from inception through commercialization and beyond, aiming to improve patient outcomes and advance medical innovation.

F-Prime Capital is a Cambridge, Massachusetts-based venture capital firm with a longstanding history of backing early- and growth-stage companies across life sciences and technology. The firm focuses on healthcare including therapeutics, medtech, and healthtech, as well as technology sectors such as enterprise software, fintech, frontier tech, and crypto ventures. Its team combines scientists, engineers, physicians, operators, and investors to provide hands-on support and strategic guidance designed to accelerate scalable growth. With a global footprint, F-Prime engages with portfolio companies across the Americas, Europe, and Asia, and maintains relationships with a wide network of industry experts to help startups advance from concept to market.

Andreessen Horowitz is a Menlo Park, California-based venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz. It funds technology startups across seed to late stages, with investments spanning software, cloud infrastructure, enterprise software and services, consumer internet, fintech, artificial intelligence, crypto, infrastructure, and biotechnology at the intersection of computer science and life sciences. The firm emphasizes supporting portfolio companies through growth and strategic partnerships and maintains a broad tech-focused investment approach, aiming to add value beyond capital.

Morningside Group is a venture capital firm founded in 1986, originally established as a family office for the Chan family, and is based in the greater Boston area. The firm makes venture investments in companies with novel science and technology, pursuing a long-term, patient approach to company-building and emphasizing ethical practices. Its investment focus spans life sciences, digital health, artificial intelligence, materials science, and information technology. In addition to its investment activities, Morningside supports charitable initiatives in education, research, and healthcare, with partnerships including the Harvard T.H. Chan School of Public Health, UMass Chan Medical School, and the MIT Morningside Academy for Design.

StartUp Health is a global health innovation organization founded in 2011 that supports entrepreneurs and health innovators to improve health and wellbeing. It partners with a broad ecosystem of founders, funders, and healthcare leaders to pursue health moonshots such as access to care, cure disease, end cancer, women’s and children’s health, mental health, and pandemic response. It operates the world’s largest portfolio of health technology companies, with more than 330 companies across six continents and 26 countries, and is backed by major health systems and investors including Kaiser Permanente, Masimo, Novartis, Otsuka, Ping An, Steve Case, Mark Cuban, and Esther Dyson. The organization focuses on collaboration, knowledge sharing, and ecosystem programs that connect startups, scaleups, established companies, and providers, and it hosts events to accelerate progress in priority health areas.

Antler is a global venture capital firm and startup incubator based in Singapore that invests in early-stage technology companies and supports startups across sectors including healthcare, finance, consumer, and software. It builds a worldwide community of co-founders and provides access to talent, mentors, and expert advisors, along with expansion support and capital to help teams form, validate business models, and grow internationally. Antler emphasizes long-term partnerships with portfolio companies, continuing to back ventures through growth stages as they scale.

Right Side Capital Management is a San Francisco-based venture capital firm founded in 2012 that targets early-stage, capital-efficient technology startups in the United States and Canada. The firm employs a data-driven, quantitative approach to investment decisions and aims for rapid yes-or-no conclusions, often within two weeks. Typical rounds encompass small checks in the low hundreds of thousands, with the potential for larger commitments in exceptional cases, and a portfolio-wide strategy that emphasizes diversification. Beyond capital, it provides hands-on mentorship in areas such as sales, marketing, and fundraising, leveraging a network of investors and seasoned operators to support portfolio companies after investment. The firm focuses on teams still refining product-market fit, including those outside traditional tech hubs, and seeks to help founders scale efficiently through structured operational support and transparent decision processes.

Qiming Venture Partners is a global venture capital firm founded in 2006 with offices in Shanghai, Beijing, Suzhou, Hong Kong, and Singapore. It manages multiple funds and more than $9.5 billion in committed capital, investing across healthcare, information technology, new consumer patterns, mobile internet, AI, robotics, and related sectors. The firm backs early to growth-stage companies, including numerous healthcare, tech and consumer businesses, and has built a broad portfolio exceeding several hundred companies with a substantial track record of exits, including IPOs and M&A. It operates a U.S. presence to back cross-border opportunities and emphasizes a hands-on approach, leveraging industry resources and an extensive network to support portfolio companies through strategic decisions, governance, and scaling. The portfolio spans marquee names and innovative startups, reflecting a focus on accelerating China's innovation and delivering long-term value for entrepreneurs and stakeholders.

Deerfield Management is a New York City–based healthcare investment and information platform that advances health outcomes through flexible funding, data-driven insights, and philanthropic support. The firm invests in and builds healthcare companies across biotechnology, pharmaceuticals, diagnostics, medical devices, healthcare services, and digital health, leveraging a dedicated research and development engine, Deerfield Discovery and Development, and in-house facilities that support scientific collaboration and discovery. Its Intelligence offering uses AI, data and market research to drive technology and strategy across its portfolio and the broader healthcare ecosystem. Deerfield operates the Cure hub housing portfolio companies and modern labs, and has partnered with organizations such as Blue Cross Blue Shield of North Carolina to develop services like Alo that assist independent physicians in managing the business of medicine. The Deerfield Foundation funds education, healthcare access and health outcomes initiatives, reflecting a broader philanthropic approach to accelerating medical innovation through partnerships and strategic collaborations.

Town Hall Ventures is a New York-based venture capital firm established in 2018 that concentrates on early-stage healthcare companies across the United States, with a particular emphasis on technology-enabled care delivery and health outcomes for underserved and high-need populations. The firm targets Series A and Series B investments in healthcare technology and related services, aiming to transform the U.S. health care market. It differentiates itself through substantial, hands-on support and by leveraging strategic relationships to help founders build meaningful, scalable businesses. Town Hall partners with entrepreneurs to accelerate growth and improve access to care in areas such as mental health, senior care, rural health, and other underserved segments, seeking category-defining opportunities that can impact millions of lives.

Stamford, Connecticut-based venture and growth equity firm focused on healthcare information services and financial services technology. Founded in 2014, Oak HC/FT backs companies in the United States and Europe, aiming to transform healthcare and fintech through strategic counsel, board-level involvement, and access to a broad industry network. The firm invests in growth and early-stage opportunities, typically deploying tens of millions of dollars per deal, and supports portfolio companies across their lifecycle. Oak HC/FT is affiliated with Oak Investment Partners’ healthcare and fintech teams, reflecting a sector-focused approach. The firm has a track record of notable exits, including IPOs and multiple portfolio companies valued at over $1 billion.

New Enterprise Associates is a United States-based venture capital firm founded in 1977 and headquartered in Menlo Park, California. It invests in technology and healthcare companies across multiple stages, from seed to growth and IPO, and provides strategic support in product development and market expansion. The firm targets sectors including software, AI, consumer technology, digital health, life sciences, and energy technology, and pursues opportunities worldwide. NEA emphasizes long-term partnerships with founders, drawing on domain expertise and a broad network to help portfolio companies scale. It maintains a diverse portfolio across the United States, Asia and other regions, reflecting a global approach to venture investing.

Vivo Capital is a global healthcare investment firm founded in 1996 and headquartered in Palo Alto, California, with offices in Asia. The firm manages approximately $5.8 billion in assets under management and has invested in over 290 public and private healthcare companies worldwide. Its multi‑fund platform covers growth equity, private equity including buyouts, venture capital, and public equity, and it makes investments across biotechnology, pharmaceuticals, medical devices, and healthcare services in major markets, with a focus on the United States and China. The team comprises about 50 professionals including physicians, scientists, entrepreneurs, operating executives, and industry experts who collaborate to build and grow high‑quality healthcare companies.

BoxGroup, founded in 2009, is a New York-based venture capital firm that backs early-stage technology startups, typically at pre-seed to Series A, across sectors including consumer, enterprise software, fintech, healthcare, life sciences, SaaS, marketplaces, e-commerce, climate tech, and frontier technologies. The firm emphasizes supporting solo founders and bold ideas, evaluating teams with conviction and aiming to fund ventures at the start of emerging markets. Investment sizes vary from tens of thousands to around a million dollars, with a global outlook and a stated focus on New York City, Silicon Valley, and Los Angeles, though geography is not a constraint. BoxGroup operates as a boutique investor in the early stages of portfolio companies, often engaging without taking board seats.

Eli Lilly and Company is a global pharmaceutical company focused on discovering, developing, manufacturing, and marketing medicines across neuroscience, cardiometabolic, cancer, and immunology areas. It operates manufacturing and distribution facilities in the United States, Puerto Rico, and about 25 other countries, with products sold in roughly 135 countries. The company emphasizes ongoing research to create therapies that address unmet medical needs and to improve patient outcomes. Its portfolio spans treatments for diabetes and metabolic conditions, cancer, autoimmune diseases, and other serious conditions.

Frist Cressey Ventures is a Nashville-based venture capital firm focused on healthcare and digital health. Founded in the mid-2010s, it targets early- and growth-stage companies, providing capital alongside strategic support to help portfolio companies scale. The firm works closely with executives through structured advisory and evaluation processes, offering guidance on leadership development, talent acquisition, and organizational growth, and facilitates partnerships, mentorship, and ecosystem connections to navigate the healthcare landscape. Its investment approach aims to improve patient access, affordability, and outcomes by backing innovative solutions across diverse areas, including clinical workflow, data networks, and health technology, while modernizing care delivery and accelerating cell and gene therapies. Frist Cressey Ventures seeks to advance patient experiences and efficiency, reduce costs, and support sustainable growth in healthcare enterprises.

Gaingels is a venture investment syndicate focused on supporting LGBTQ founders and inclusive leadership by investing across stages and partnering with other venture firms to back diverse, high-potential companies. It maintains a global portfolio of 130+ companies and has deployed tens of millions in capital to date. The organization actively helps portfolio companies identify and recruit diverse talent for C-suite and board roles and cultivates a worldwide network of investors, operators, and entrepreneurs who share a commitment to positive social change through business.

Novo Nordisk is a global healthcare company focused on discovering, developing, and delivering medicines for serious chronic diseases, with a core emphasis on diabetes care. The organization produces and distributes insulin and other therapies aimed at treating diabetes and related conditions, while investing heavily in scientific research and biopharmaceutical innovation. Through partnerships and sustained commitments to accessibility, Novo Nordisk seeks to improve patient outcomes and support health systems worldwide. The company operates across many markets, supported by its production of insulin pens and a broad portfolio addressing obesity, rare blood and endocrine disorders, and other chronic diseases. It pursues long-term social responsibility and sustainability as integral to its business model.

HealthTech Capital is a membership-based angel investor network and mentoring program founded in 2010 and based in Los Altos Hills, California. It connects accredited angel investors with early-stage health technology and medical technology startups, healthcare systems, venture and corporate partners, and clinical providers to foster deal flow and collaboration. The organization supports portfolio companies through mentoring, networking initiatives, and access to its broad network across the United States and Asia, with activities that combine funding and guidance to accelerate the development of innovative healthcare technologies at the intersection of healthcare, technology and mobility.

Transformation Capital is a Boston-based growth and expansion firm that invests in healthcare technology and services companies across the United States. It supports digital health, AI-driven research and development, telehealth, and workforce solutions, aiming to create a more accessible, efficient, and innovative healthcare system. As an independent management company with roots in Leerink Transformation Partners, Transformation Capital pursues new opportunities in healthcare innovation and oversees investments that build infrastructure for regulated AI and scalable care delivery.

Khosla Ventures is a California-based venture capital firm founded in 2004 that provides capital and strategic support to technology-driven startups across early- to late-stage cycles. It pursues opportunities in AI, digital health, healthcare technologies, sustainability, fintech, consumer and enterprise technology, and other frontier areas, focusing on innovative business models and world-class teams. The firm emphasizes a contrarian, long-term approach and seeks to help entrepreneurs address meaningful societal and economic challenges through science, technology, and design.

Pfizer is a leading global biopharmaceutical company that discovers, develops, manufactures, and markets medicines and vaccines to address unmet medical needs. It maintains a broad portfolio across prescription medicines, vaccines, and treatments spanning internal medicine, inflammation and immunology, oncology, and other therapeutic areas, and it operates a sizable pipeline of investigational products with potential to address major diseases. The company conducts extensive global sales, with international markets contributing a substantial share of revenue, and it emphasizes scientific innovation, transparency, patient access, and ethical business practices. Its well-known products include Prevnar 13 and Eliquis, among others, and it continues to invest in research and development to advance new therapies. Based in the United States, Pfizer has a long history dating back to the 19th century and maintains a global footprint through manufacturing, partnerships, and philanthropic initiatives aimed at improving health outcomes worldwide.

SMBC Venture Capital is the venture capital arm of Sumitomo Mitsui Banking Corporation, focusing on growth equity and buyouts across information technology, life sciences, services, and manufacturing. Founded in 2005 and headquartered in Tokyo with an office in Osaka, it leverages the SMBC network to connect portfolio companies with large corporates, talent, and specialists, providing stage-appropriate, coordinated support through its integrated team. The firm pursues a long-term, growth-focused approach and invests across industries and stages, aiming to back companies that improve lives and address social challenges. Its portfolio has included more than 400 companies that have achieved initial public offerings, reflecting its emphasis on value creation alongside entrepreneurs.

Liquid 2 Ventures is a San Francisco-based venture capital firm founded in 2015 by Joe Montana, Mike Miller, and Michael Ma. It provides seed- and early-stage capital to technology startups, occasionally supporting later rounds such as Series B, and often invests alongside co-investors. The firm emphasizes strategic introductions and hands-on guidance to help portfolio companies scale, with a focus on software, TMT, and other technology sectors. By partnering with founders and other investors, Liquid 2 Ventures aims to align capital with long-term company growth.

Echo Health Ventures is a venture capital firm focused on investing in healthcare, health technology, insurance technology, and digital health companies in the United States. Founded in 2016, the firm operates with offices in Durham, Portland, and Seattle and pursues stage-agnostic investments to accelerate portfolio innovations and scale them nationally. It emphasizes strategic, long-term partnerships that go beyond capital, aiming to develop deep, high-value relationships with portfolio companies. The firm supports systemic healthcare transformation through collaboration and industry initiatives such as the Echo Innovation Alliance.

Lux Capital is a venture capital firm focused on investing in companies at the intersection of science, technology, and industry. The firm backs ventures applying research across sectors including artificial intelligence, biotechnology, advanced materials, space, and energy, with an emphasis on translating complex innovations into scalable businesses. Lux provides capital together with strategic input on product development, company building, and long-term positioning, and takes an active role to help founders navigate technical and market challenges. The firm evaluates opportunities based on the underlying science, potential industry impact, and feasibility of execution over extended horizons. With offices in New York and Silicon Valley, Lux collaborates with technical founders, researchers, and teams to build durable market leaders and accelerate scientific breakthroughs into real-world applications.

Founded in 1985, The Invus Group is a global private equity firm that partners with entrepreneurs, founders and management teams across the company lifecycle. Blending a family-office approach with multi-strategy investing, it supports transformative growth in sectors including consumer products and services, technology, life sciences, software, agtech, industrials, education and medical devices. The firm pursues long-term value creation through strategic insight, capital and execution, investing in companies from early stages to mature businesses and providing both lead investments and co-investments in private transactions worldwide. It maintains a global footprint with offices in New York, London, Paris and Hong Kong and has a flexible structure designed to align incentives with partners over time.

LRVHealth is a Boston-based healthcare venture capital platform that connects entrepreneurs with a network of healthcare organizations to validate and scale digital health, care-delivery solutions, data analytics, and administrative technologies used by providers and payers. Since its founding in 2000, it has focused on early-stage and growth investments in software and healthcare technology, offering strategic guidance, market insights, and introductions to operators to support pilots, adoption, and integration into existing workflows. The firm emphasizes deep industry expertise, including healthcare labor markets, and collaborates with portfolio companies to refine product-market fit while navigating regulatory and reimbursement environments.

The European Innovation Council is a Brussels-based European Union organization established in 2018 to support deep‑tech innovation by helping startups, researchers and technology transfer activities move ideas toward market. It operates a portfolio of programs including Pathfinder, Accelerator, Transition, STEP Scale Up and Pre-Accelerator, and collaborates with partners to provide funding, mentorship and resources across the innovation lifecycle. The council emphasizes high-impact, science‑driven technologies with broad societal benefit and promotes inclusion, with initiatives to involve women‑led projects. It engages the wider ecosystem through awards, events and community initiatives and monitors impact through data platforms. By coordinating with private investors and other stakeholders, it aims to accelerate the scale-up of European deep‑tech firms and strengthen Europe’s position in global technology leadership.

Torch Capital is a New York-based early-stage venture capital firm that backs consumer technology startups and the infrastructure that powers them. It focuses on AI-powered companies and a broad portfolio spanning AI/Infrastructure, Health & Wellness, Culture & Entertainment, Finance & Governance, and Ecommerce, with the aim of transforming how consumers and businesses operate. The firm takes a hands-on approach, supported by an experienced team of entrepreneurs, executives, and industry veterans who provide strategic guidance and access to networks to help portfolio companies scale and achieve impact. Founded in 2018, it pursues active collaboration with founders to advance disruptive technologies.

Maverick Capital is a global investment firm founded in 1993 with offices in New York, San Francisco, London, Hong Kong, Philadelphia and Dallas. It invests across public equities and private markets, including Maverick Ventures, the venture arm that backs early to growth stage companies in healthcare, software and deep technology and frequently leads rounds and takes board seats. The firm operates Maverick Silicon, a dedicated semiconductor platform. With a focus on fundamental research, Maverick Capital partners with portfolio teams to build businesses and seeks to preserve and grow capital for its clients. The firm supports a diverse investor base and has built a long history of investing in disruptive technologies across geographies.

SV Angel is a San Francisco-based venture capital firm established in 1992 that concentrates on seed to early-stage technology investments, notably in software and AI, primarily in the United States. The firm emphasizes long-term partnerships with founders and provides strategic support, business development, financing and M&A advice, leveraging its extensive network to offer introductions and resources beyond capital. Its portfolio includes OpenAI, Databricks, Eventbrite, Cedar and Vercel, illustrating a track record of backing transformative technology companies and helping them grow.

Mission BioCapital is a life sciences venture capital firm established in 2009 and based in Cambridge, Massachusetts, that funds early-stage biotechnology companies and supports them through clinical development. The firm emphasizes mentorship and practical assistance, offering entrepreneurs access to laboratory space, incubator networks, and programs designed to accelerate progress and secure follow-on funding. Its approach combines capital with hands-on guidance across discovery, development, and commercialization, leveraging a history of supporting dozens of startups. Through a broad ecosystem in the United States and Europe, Mission BioCapital aims to translate scientific discoveries into tangible solutions by pairing funding with operational support, expert advice in areas such as drug discovery, legal, and accounting, and strategic mentorship to help portfolio companies reach milestones and attract subsequent investment.

Bossa Invest is a venture capital firm based in São Paulo, Brazil, founded in 2011. It focuses on software-as-a-service startups in Latin America, providing growth capital, mentorship, and access to a broad network of strategic partners and co-investors to help portfolio companies scale, and operates a corporate venture capital arm that collaborates with corporate partners through flexible operating models and end-to-end support.

Goodwater Capital is a San Francisco Bay Area based consumer technology investment firm that backs early-stage startups worldwide, focusing on consumer technology and fintech. Founded in 2014 and headquartered in Burlingame, California, it supports ventures from Series A to IPO using software enabled, data driven approaches to help founders scale and reach millions of customers. It provides portfolio companies with detailed data, concierge services, startup curricula, and strategic advice to accelerate growth across housing, healthcare, food delivery, financial services, education, entertainment, and transportation. The portfolio targets consumer products and services, software, and related sectors, aiming to drive measurable social impact and substantial value for both entrepreneurs and investors.

Health Velocity Capital is a San Francisco-based investment firm focusing on growth-stage investments in healthcare software and services in the United States. Drawing on more than 25 years of experience fueling healthcare innovation, the firm partners with companies developing software, services, and solutions that improve patient care, operational efficiency, and affordability. It emphasizes revenue growth and strong teams to create durable value, and it invests across healthcare technology, services, and related facilities. By supporting scalable models and strategic exits, Health Velocity Capital aims to advance a more affordable, sustainable, and accessible healthcare system for consumers.

Ben Franklin Technology Partners of Southeastern Pennsylvania is a nonprofit organization founded in 1982 that supports the technology ecosystem in Southeastern Pennsylvania by providing capital, guidance, and connections to early-stage technology companies. It acts as a seed-stage capital provider for the region's technology sectors, facilitates university-industry partnerships to accelerate commercialization, and undertakes initiatives to strengthen the entrepreneurial community across Philadelphia and surrounding counties, with a focus on creating jobs and fostering regional innovation.

HLM Venture Partners is a Boston-area private equity and venture capital firm focused on healthcare. Founded in 1983 and based in Waltham, Massachusetts, the firm backs early-stage and growth companies operating in healthcare technology, services, and life sciences across the United States. It leverages deep industry expertise, an established network, and strategic partnerships to guide portfolio companies from concept to market leadership. With a history of supporting more than 60 healthcare companies, HLM emphasizes long-term relationships, rigorous business and financial guidance, and value creation through operational and strategic support. The firm collaborates closely with founders and management teams to transform innovative ideas into scalable, market-leading businesses, drawing on a track record of hands-on involvement and a reputation for integrity and longevity in the healthcare ecosystem.

Flare Capital Partners is a Boston-based venture capital firm focused on healthcare technology. It backs early-stage and growth-stage companies across the United States, investing in software, data, artificial intelligence, digital health, medical devices, and related healthcare IT solutions that enable value-based care. The firm emphasizes transformational technologies and leverages a network-driven engagement model, including an AI Advisory Council and Industry Advisory Board of healthcare leaders, to support portfolio companies and accelerate adoption with near-term ROI. Its approach aims to connect innovators with buyers and to generate impact within the broader healthcare economy.

Service Provider Capital is a Colorado-based venture capital firm founded in 2014 that co-invests in seed and Series A rounds led by institutional venture funds. It operates six regional funds across the Rocky Mountain, Midwest, New England, Southeast, Texas, and Pacific Northwest regions and supports more than 600 portfolio companies with a network of more than 400 strategic investors, providing access to its LP and CEO networks, and facilitating connections with venture funds, strategic partners, potential customers, and key hires. Each regional fund is managed by dedicated partners to deliver timely, hands-on support for portfolio companies. The firm maintains a presence in Colorado with operations in Vail and Golden.

Pear VC is a California-based venture capital firm founded in 2013 in San Francisco that concentrates on pre-seed and seed-stage technology investments. The firm provides comprehensive support to its portfolio companies, including in-house recruiting, talent acquisition, go-to-market strategy, fundraising assistance, and PR and marketing programs, with tailored founder-focused playbooks and investor introductions. Pear emphasizes long-term partnerships with founders and seeks to build strong networks through initiatives such as Pear Garage. Its investment scope covers artificial intelligence, software as a service, enterprise technology, healthcare, biotechnology, climate technology, fintech, and consumer sectors, among others. Historically, Pear has seeded notable startups early, highlighting its role in helping exceptional founders shape the future of technology.

Alexandria Venture Investments is the strategic venture capital arm of Alexandria Real Estate Equities. It provides seed through growth capital to life science and technology companies developing breakthrough therapies, diagnostics, research tools, agrifoodtech, agtech, digital health, and related platforms. Backed by the parent company’s industry experience and scientific advisory network, the firm leverages long-standing relationships and domain expertise to support early to growth-stage ventures aiming to translate scientific advances into practical healthcare and technology solutions.

Canaan Partners is a global early-stage venture capital firm founded in 1987 and headquartered in San Francisco. It focuses on supporting technology and healthcare startups at the seed and early stages, investing across sectors such as fintech, enterprise software and cloud, marketplaces, frontier technologies, biopharma, digital health and medtech. The firm maintains an international footprint with offices in Israel and India and backs entrepreneurs by leveraging a broad network of strategic partners, customers and follow-on investors to help transform innovative ideas into global companies.

FJ Labs is a New York-based venture capital firm that focuses on marketplaces and consumer-facing startups. It is stage-agnostic, backing seed and Series A rounds, with an investment range of fifty thousand to five million dollars. Founded in 2015 by Fabrice Grinda, the firm leverages its network and experience in the marketplace sector to support founders aiming for rapid growth. The firm maintains a broad portfolio across e-commerce, on-demand services, fintech, and related technologies, with notable investments in Alibaba, Coupang, Delivery Hero, Beepi, BrightRoll, Betterment, Adore Me, and Earnest. FJ Labs emphasizes partnerships with visionary founders and uses its sector expertise to help portfolio companies scale and achieve expansion.

Revolution is a Washington, D.C.-based venture capital firm founded in 2005 by Steve Case. It specializes in early- and growth-stage investments across technology-enabled sectors including software and services, consumer internet, media and entertainment, health, financial services, energy, and education, with a track record of backing entrepreneurs who build companies outside traditional coastal hubs. The firm emphasizes investing in underserved or emerging startup communities through its Rise of the Rest initiative, which spotlights regional ecosystems and funds seed- and early-stage companies outside New York, Silicon Valley, and Boston. Revolution operates multiple funds focused on entrepreneurs nationwide and seeks to partner with top-tier investors, often taking leading roles and board seats to help portfolio companies scale.

Venrock is a Palo Alto-based venture capital firm, founded in 1969 as the venture capital arm of the Rockefeller family. It focuses on seed and early-stage investments in technology and healthcare, supporting founders with strategic guidance and long-term growth. The firm has backed a broad portfolio of notable companies across software, semiconductors, healthcare, and consumer technology, including Apple, Intel, Illumina, Nest, Gilead Sciences, DoubleClick, Athenahealth, Endeca, SlideShare, and Tudou. With offices in Silicon Valley and New York, Venrock emphasizes partnership with entrepreneurs to build enduring companies through hands-on mentorship, sector expertise, and a long-term orientation. Its activity spans multiple technology and life sciences domains, including cybersecurity, AI, and digital health, reflecting a consistent track record of helping portfolio companies scale and achieve exits.